Intra-arterial delivery is not superior to intravenous delivery of autologous bone marrow mononuclear cells in acute ischemic stroke.
about
Clinical Trials of Adult Stem Cell Therapy in Patients with Ischemic StrokeAdult Stem Cell Therapy for Stroke: Challenges and ProgressCXCR4(+)CD45(-) BMMNC subpopulation is superior to unfractionated BMMNCs for protection after ischemic stroke in micePreconditioning with VEGF Enhances Angiogenic and Neuroprotective Effects of Bone Marrow Mononuclear Cell Transplantation in a Rat Model of Chronic Cerebral HypoperfusionSystematic Review and Meta-Analysis of Bone Marrow-Derived Mononuclear Cells in Animal Models of Ischemic Stroke.Stem cell-based treatments against stroke: observations from human proof-of-concept studies and considerations regarding clinical applicability.Intra-arterial delivery of human bone marrow mesenchymal stem cells is a safe and effective way to treat cerebral ischemia in rats.Effect of mesenchymal precursor cells on the systemic inflammatory response and endothelial dysfunction in an ovine model of collagen-induced arthritisWhite matter injury restoration after stem cell administration in subcortical ischemic stroke.Neuronal Interleukin-4 as a Modulator of Microglial Pathways and Ischemic Brain DamageIntravenous Autologous Bone Marrow Mononuclear Cell Transplantation for Stroke: Phase1/2a Clinical Trial in a Homogeneous Group of Stroke PatientsBone marrow mononuclear cell therapy in ischaemic stroke: a systematic review.Autologous Bone Marrow Mononuclear Cells Exert Broad Effects on Short- and Long-Term Biological and Functional Outcomes in Rodents with Intracerebral Hemorrhage.Cryopreservation of Bone Marrow Mononuclear Cells Alters Their Viability and Subpopulation Composition but Not Their Treatment Effects in a Rodent Stroke Model.Intranasal delivery of bone marrow-derived mesenchymal stem cells, macrophages, and microglia to the brain in mouse models of Alzheimer's and Parkinson's disease.Stroke Induces Mesenchymal Stem Cell Migration to Infarcted Brain Areas Via CXCR4 and C-Met Signaling.Adipose tissue-derived mesenchymal stem cells as a strategy to improve recovery after stroke.Concise Review: Cell Therapies for Stroke and Traumatic Brain Injury: Targeting Microglia.Stem Cell-Based Therapies for Ischemic Stroke: Preclinical Results and the Potential of Imaging-Assisted Evaluation of Donor Cell Fate and Mechanisms of Brain Regeneration.Is Immunomodulation a Principal Mechanism Underlying How Cell-Based Therapies Enhance Stroke Recovery?Inflammation and Stroke: An OverviewStem cell therapies in age-related neurodegenerative diseases and stroke.A two-year follow-up study of cotransplantation with neural stem/progenitor cells and mesenchymal stromal cells in ischemic stroke patients.Phase I/II randomized controlled trial of autologous bone marrow-derived mesenchymal stem cell therapy for chronic stroke.Various Cell Populations Within the Mononuclear Fraction of Bone Marrow Contribute to the Beneficial Effects of Autologous Bone Marrow Cell Therapy in a Rodent Stroke Model.Intra-arterial transplantation of low-dose stem cells provides functional recovery without adverse effects after stroke.Real-time MRI for precise and predictable intra-arterial stem cell delivery to the central nervous system.Age of donor of human mesenchymal stem cells affects structural and functional recovery after cell therapy following ischaemic stroke.Protective Effects of Autologous Bone Marrow Mononuclear Cells After Administering t-PA in an Embolic Stroke Model.Intravenously Transplanted Human Bone Marrow Endothelial Progenitor Cells Engraft Within Brain Capillaries, Preserve Mitochondrial Morphology, and Display Pinocytotic Activity Toward Blood-Brain Barrier Repair in Ischemic Stroke Rats.Breaking the Blood-Brain Barrier With Mannitol to Aid Stem Cell Therapeutics in the Chronic Stroke Brain.Potential of Stem Cell-Based Therapy for Ischemic Stroke.
P2860
Q26776494-E0FECAD1-8016-44E7-9159-507E64E9D02DQ28066235-57C0D23A-4F55-4C3E-9BFB-405BC1EDFB4CQ28254272-6BD55D42-AB3B-4D4B-8F13-5ED569F1F43DQ28269380-997530F1-1124-4B67-BA04-682E038EA3B5Q30387946-9FAD1672-ED28-4B4B-9693-B2F39A63A1BCQ34419548-006D5561-9A35-46AB-ACFE-9C16E72B5524Q35396013-1EFFEBE9-D1BF-41EB-906C-684C03204F75Q35581715-5A814FCB-9C8F-4E15-BD96-65630EF63FB8Q35885598-9DB99DC3-E241-4C62-9A81-D1FA54FEEC2BQ35941396-5EE19227-44FC-49EB-B966-6637FCE9E6ABQ36092131-65B6CA76-1142-4BBB-B023-F0C57F26183AQ36112236-EEF5BBCB-19AD-4648-8D21-3F88B7F3B990Q36301669-65A04B17-B60E-466C-B6BB-26C0EF51B0E5Q37049533-4C6A2FA1-9231-4BC6-B479-F475A497F830Q38303586-26E976DF-0BB8-4AB6-A545-269D70223060Q38402505-0476A810-564F-4EBF-9228-9A9587CFB7EAQ38469989-337CA1AB-75DD-4D3D-A623-18D358381A24Q38722542-AEC0017D-92DE-4111-800F-6461ED9E0349Q38903653-7EF77942-87B8-4249-A3BE-892DC8E1521EQ38916628-C1E8F744-475F-485F-A6F6-1E1F98AE73ABQ38978527-993F989B-735B-46A5-9872-1099E4F560AFQ39017141-423813CB-0CCF-43B0-BB83-0C2C6EB87F17Q40185923-BF2D449A-DAA4-4CA4-82CB-06EFE05BCFDEQ41608195-5AA8F8FA-8983-4F76-8C03-2B37D1167DDFQ41975448-93987766-2799-46A7-BE51-4D71782B692AQ44014320-26D9943F-C5A7-4F47-A847-74B2195632D1Q46490500-605D9D89-5EE7-4F41-B3C9-47A9E4A9A62CQ47797257-6C1BBB03-A0B0-4C56-AA67-EC78ECEB932BQ48142151-EC2D4C1B-7E2D-49F5-859A-19AAFA8652E3Q48331191-C01E1744-9F80-4150-A2CC-B14EB67A7ABEQ48901226-15CA36A0-E13E-4994-871B-71E0C4D11626Q50238514-37226A04-7877-45B5-88D8-D6884F1A40C7
P2860
Intra-arterial delivery is not superior to intravenous delivery of autologous bone marrow mononuclear cells in acute ischemic stroke.
description
2013 nî lūn-bûn
@nan
2013年の論文
@ja
2013年論文
@yue
2013年論文
@zh-hant
2013年論文
@zh-hk
2013年論文
@zh-mo
2013年論文
@zh-tw
2013年论文
@wuu
2013年论文
@zh
2013年论文
@zh-cn
name
Intra-arterial delivery is not ...... ells in acute ischemic stroke.
@en
Intra-arterial delivery is not ...... ells in acute ischemic stroke.
@nl
type
label
Intra-arterial delivery is not ...... ells in acute ischemic stroke.
@en
Intra-arterial delivery is not ...... ells in acute ischemic stroke.
@nl
prefLabel
Intra-arterial delivery is not ...... ells in acute ischemic stroke.
@en
Intra-arterial delivery is not ...... ells in acute ischemic stroke.
@nl
P2093
P2860
P1433
P1476
Intra-arterial delivery is not ...... cells in acute ischemic stroke
@en
P2093
Elton Migliati
Jaroslaw Aronowski
Krystal Schaar
Sean I Savitz
XiaoPei Xi
P2860
P304
P356
10.1161/STROKEAHA.111.000821
P407
P577
2013-10-10T00:00:00Z